A Less Radical Approach
Some women with early-stage cervical cancer may be able to receive simple hysterectomy, which reduces the risk of complications.
Progress Against Cancer
Some women with early-stage cervical cancer may be able to receive simple hysterectomy, which reduces the risk of complications.
A mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
Surgical oncologist Samilia Obeng-Gyasi describes research that shows chronic stress is associated with higher mortality in cancer.
What experts forecast for cancer research and treatment in 2024. Part 1: Catherine J. Wu, MD, FAACR, on cancer vaccines.
The FDA will review a blood test that detects colon cancer, and a writer recounts his sister’s decision to receive medical aid in dying.
Highlights of December 2023 AACR journals include clinical trial results, strategies to improve therapy, and a new cervical cancer screening method.
Charles Swanton, MD, PhD, FAACR, spoke on the role chromosomal instability plays in breast cancer evolution.
In the final quarter of 2023, the FDA issued 17 approvals specifically for the treatment of tumors.
SABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
“What will you do Monday morning?” was the question posed by the final session on the final full day of the 2023 San Antonio Breast Cancer Symposium (SABCS), held Tuesday, December 5 to Saturday,...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More